Serotype 2 Marek's disease vaccine

Details Serotype 2 Marek's disease vaccine Serotype 2 Marek's disease vaccine

1987-07-10

1990-01-23

Huleatt, Jayme A.

Drug, bio-affecting and body treating compositions

Lymphokine

424 93, 4351721, 435237, 435948, 935 63, 935 65, 935 70, A61K 3912, A61K 3700, C12N 1500, C12N 708, C12R 191

Patent

active

048957186

ABSTRACT:
A serotype 2 Marek's disease vaccine comprising a cloned strain designated as 301B/1 has been derived from a field isolate. This strain is characterized by superior levels of replicative ability and protectivity in chickens as compared to existing commercial serotype 2 strains, and it is virtually nonpathogenic. 301B/1 is particularly useful in the formulation of highly efficacious bivalent and polyvalent vaccines.

REFERENCES:
patent: 4160024 (1979-07-01), Schat et al.
Paoletti et al (1984), PNAS, 81:193.
R. L. Witter, "Characteristics of Marek's Disease Viruses Isolated from Vaccinated Commercial Chicken Flocks: Association of Viral Pathotype with Lymphoma Frequency," Avian Dis. 27(1): 113-132 (Jan.-Mar. 1983).

Affiliated with

Also associated with

Rating

Serotype 2 Marek's disease vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Serotype 2 Marek's disease vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Serotype 2 Marek's disease vaccine will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-644646